Erlangen

DGAP-News: PAION AG ANNOUNCES CHANGE IN MANAGEMENT BOARD

Retrieved on: 
Friday, April 1, 2022
Company, University, Septic, Anesthesia, Aachen, Health, Distributive shock, CFO, Supervisory board, Multiplicity of infection, Financial Oversight and Management Board for Puerto Rico, Hoffmann-La Roche, CEO, Angiotensin, EU, ISIN, Critical care, MBA, Frankfurt Stock Exchange, Hypotension, Erlangen, Patient, Remimazolam, Management, Pharmaceutical industry, Central Europe

Aachen (Germany), 30 March 2022 - The specialty pharmaceutical company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8) today announces that Sebastian Werner has been appointed by the Supervisory Board as a new member of the Management Board in the position as Chief Financial Officer ("CFO") of PAION AG with effect from 1 June 2022.

Key Points: 
  • Aachen (Germany), 30 March 2022 - The specialty pharmaceutical company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8) today announces that Sebastian Werner has been appointed by the Supervisory Board as a new member of the Management Board in the position as Chief Financial Officer ("CFO") of PAION AG with effect from 1 June 2022.
  • "With his many years of international expertise in the pharmaceutical industry, Sebastian Werner is an excellent addition to the Management Board of PAION AG.
  • I wish him every success in his new role," said Dr. Jrg Spiekerktter, Chairman of the Supervisory Board of PAION AG.
  • "My special and sincere thanks also go to Mr. Omari for his successful work and great commitment to PAION over the past 14 years," commented Dr. Jrg Spiekerktter, Chairman of the Supervisory Board of PAION AG.

Flywheel and Siemens Healthineers Partner for Healthcare Research Collaboration

Retrieved on: 
Monday, July 19, 2021
Software, Research, Networks, General Health, Internet, Pharmaceutical, Data management, Technology, Clinical trials, Science, Biotechnology, Health, Engines, Manufacturing, Siemens, Secondary sector of the economy, Erlangen, Siemens Healthineers, Cloud infrastructure, Cloud computing

Flywheel , the leading data management platform for medical research and collaboration, today announced a partnership and enterprise license agreement with Siemens Healthineers.

Key Points: 
  • Flywheel , the leading data management platform for medical research and collaboration, today announced a partnership and enterprise license agreement with Siemens Healthineers.
  • Under the agreement, Flywheel will deliver a cloud-based research collaboration solution on the Siemens Healthineers teamplay digital health platform .
  • The combined research and collaboration solution will enable Siemens Healthineers collaboration teams to streamline communication, data sharing, and solutions development with their research partners.
  • Based on our Flywheel solution, Siemens Healthineers is taking a big step forward in transforming healthcare research collaboration.

France In-Vitro Diagnostics (IVD) Market Report 2021-2026: Industry Trends, Growth, Opportunity Company Overview, Sales Analysis, Impact of COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 8, 2021
Medical devices, Health, Companies, Industry economics), Erlangen, Siemens, Siemens Healthineers, IVD, Thermo Fisher Scientific, Danaher Corporation, Roche Diagnostics, Sysmex Corporation, Cepheid

The "France In-Vitro Diagnostics (IVD) Market, Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview, Sales Analysis, Forecast" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "France In-Vitro Diagnostics (IVD) Market, Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview, Sales Analysis, Forecast" report has been added to ResearchAndMarkets.com's offering.
  • France In-Vitro Diagnostics market is expected to reach US$ 2.1 Billion by the end of the year 2026.
  • Another important IVD market in France is that the country's private medical analysis laboratories merge into larger units.
  • Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific and Sysmex Corporation are prime companies in the France In-Vitro Diagnostics (IVD) Market.

Siemens Healthineers Announces FDA Clearance of MAGNETOM Free.Max 80 cm MR Scanner

Retrieved on: 
Tuesday, July 6, 2021
Medical devices, FDA, Health, Hospitals, Managed care, Radiology, Erlangen, Siemens, Siemens Healthineers, Magnetic resonance imaging, Scan, Medicine, Health care, Cities in Germany

Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of the MAGNETOM Free.Max, a new High-V magnetic resonance (MR) scanner that combines a 0.55 Tesla (0.55T) field strength with deep learning technologies and advanced image processing.

Key Points: 
  • Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of the MAGNETOM Free.Max, a new High-V magnetic resonance (MR) scanner that combines a 0.55 Tesla (0.55T) field strength with deep learning technologies and advanced image processing.
  • By doing so, the scanner broadens the range of MR clinical applications and provides customers with the inherent clinical benefits of a mid-field MR scanner.
  • The first and only 80 cm wide-bore system available, the MAGNETOM Free.Max also facilitates MR scanning for extremely obese and claustrophobic patients, enhancing the patient experience.
  • At less than 3.5 tons and less than 80 inches high, the MAGNETOM Free.Max is the most lightweight, compact whole-body scanner ever offered by Siemens Healthineers.

Siemens Healthineers and Prisma Health Join Forces to Innovate Healthcare for South Carolina

Retrieved on: 
Tuesday, June 22, 2021
Technology, Infectious diseases, Other Technology, Biotechnology, Other Health, Managed care, Health, General Health, Data management, Privacy law, Articles, Companies, Manufacturing, Siemens, Erlangen, Siemens Healthineers, Prisma Health, Preferred Reporting Items for Systematic Reviews and Meta-Analyses, Medical privacy, Privacy, California Proposition 24

Siemens Healthineers and Prisma Health announced today a 10-year strategic relationship to help create a better state of health for South Carolina.

Key Points: 
  • Siemens Healthineers and Prisma Health announced today a 10-year strategic relationship to help create a better state of health for South Carolina.
  • This Value Partnership is focused on healthcare innovation, workforce development, and improving health care for patients and communities served by Prisma Health.
  • By joining forces, Siemens Healthineers and Prisma Health will now have the ability to expand and enhance the quality of healthcare available to the community, said David Pacitti, President and Head of the Americas, Siemens Healthineers.
  • Prisma Health is a not-for-profit health company and the largest healthcare system in South Carolina.

Gynesonics Appoints David Pacitti to Board Chair

Retrieved on: 
Monday, June 7, 2021
Medical devices, Health, Consumer, Surgery, Women, Radiology, Companies, Manufacturing, Industry economics), Siemens, Erlangen, Siemens Healthineers, Uterine fibroid, Sonata System, Gynesonics, SONATA SYSTEM, GYNESONICS

Gynesonics, a womens healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that David Pacitti, medical device executive and current President and Head of Siemens Healthineers for The Americas, has been appointed Chair of the company's Board of Directors.

Key Points: 
  • Gynesonics, a womens healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that David Pacitti, medical device executive and current President and Head of Siemens Healthineers for The Americas, has been appointed Chair of the company's Board of Directors.
  • Mr. Pacitti is leading the marketing, sales, service, and support functions in North America and Latin America for Siemens Healthineers.
  • We are pleased to have Dave Pacitti join the Board of Directors as the new Board Chair, said Gynesonics President and Chief Executive Officer Christopher Owens.
  • She provided Gynesonics with critically important guidance through our clinical development phase and initial product launch in her prior role as Board Chair.

Siemens Healthineers Enhances Its Order Management Process with Esker’s AI-Driven Solution

Retrieved on: 
Tuesday, May 25, 2021
Software, Finance, General Health, Health, Data management, Professional services, Technology, Other Technology, Companies, Manufacturing, Industry economics), Siemens, Information technology management, Erlangen, Siemens Healthineers, Business process management, Automation, Business process automation, Siemens Healthineers, Esker, SIEMENS HEALTHINEERS, ESKER

Esker , a global cloud platform and leader in AI-driven process automation solutions for finance and customer service functions, today announced that the Italian branch of Siemens Healthineers , an international medical technology company, is automating its order management process with Eskers Order Management solution.

Key Points: 
  • Esker , a global cloud platform and leader in AI-driven process automation solutions for finance and customer service functions, today announced that the Italian branch of Siemens Healthineers , an international medical technology company, is automating its order management process with Eskers Order Management solution.
  • To decrease the workload of the Customer Service team as well as reduce errors, Siemens Healthineers turned to Esker for a solution that would automate, standardize and streamline its order management process.
  • Today, Siemens Healthineers automates 85% of received orders, with 93% of order fields correctly identified by the solution.
  • Following the excellent results achieved in Italy, Siemens Healthineers has extended the partnership and is implementing Eskers Order Management solution in the U.S., Western and Eastern Europe, and South Africa, thereby leveraging Eskers global reach and comprehensive order management automation capabilities.

Global Smart Hospitals Market to Surpass US$ 105,245.0 Million by 2028, Says Coherent Market Insights (CMI)

Retrieved on: 
Monday, May 10, 2021
General Health, Hardware, Hospitals, Health, Technology, Companies, Telecommunications, Industry economics), Siemens, Erlangen, Siemens Healthineers, Cisco Systems, Radiology

For instance, in October 2020, the European Commission invested US$ 15.6 million in the School of Engineering at the University of Warwick, U.K., for research and development in incorporating use of robots and artificial intelligence in hospitals mainly in the U.K.

Key Points: 
  • For instance, in October 2020, the European Commission invested US$ 15.6 million in the School of Engineering at the University of Warwick, U.K., for research and development in incorporating use of robots and artificial intelligence in hospitals mainly in the U.K.
  • Successful implementation of AI to improve basic healthcare facilities by highlighting errors in prescription or predicting fall or death is expected to boost the growth of artificial intelligence in global smart hospitals market.\nMarket players are indulged in launching new products, which is expected to drive growth of the market over the forecast period.
  • For instance, in March 2020, Siemens Healthineers, a medical device company, announced the launch of ACUSON Redwood Ultrasound System at the 73rd Annual Conference of Indian Radiological & Imaging Association (IRIA) 2020, Gandhinagar, Gujarat.
  • For instance, in May 2019, STANLEY healthcare announced partnership with Cisco DNA Spaces.

Subtle Medical Awarded Breakthrough Patent for Reduced Contrast Agent Dosage in Medical Imaging Exams

Retrieved on: 
Tuesday, May 4, 2021
Companies, Industry economics), Manufacturing, Medical physics, Nuclear medicine, Erlangen, Siemens, Siemens Healthineers, Medical imaging, Medical device, Philips, Medicine

10,997,716 for their licensed innovative software that uses deep learning to drastically reduce contrast dosage needed during contrast-enhanced medical imaging exams.

Key Points: 
  • 10,997,716 for their licensed innovative software that uses deep learning to drastically reduce contrast dosage needed during contrast-enhanced medical imaging exams.
  • Greg Zaharchuk and Enhao Gong prior to co-founding Subtle Medical and is based on technology exclusively licensed from Stanford University.
  • "As a result, significantly reduced contrast agent dosage can be used to obtain diagnostic information in medical imaging, enabling safer exams for patients worldwide.
  • Subtle is currently in collaboration with top-tier medical device vendors, including Siemens Healthineers, Philips (China), and several pharmaceutical partners.

Siemens introduces PCBflow, a secure, cloud-based solution for accelerating design-to-manufacturing handoff for printed circuit boards

Retrieved on: 
Monday, April 5, 2021
Companies, Siemens, Industry economics), Manufacturing, Erlangen, Siemens Healthineers, LinkedIn, VA Tech Wabag

PCBflow is Siemens' first step toward PCB assembly online solutions which automate the design-to-manufacturing handoff process.

Key Points: 
  • PCBflow is Siemens' first step toward PCB assembly online solutions which automate the design-to-manufacturing handoff process.
  • For manufacturers, PCBflow helps simplify customer onboarding processes and provides designers with a comprehensive source of knowledge, which can streamline customer/manufacturer collaboration.
  • For more information on Siemens Digital Industries Software products and services, visit www.sw.siemens.com or follow us on LinkedIn , Twitter , Facebook and Instagram .
  • Via its majority stake in the publicly listed company Siemens Healthineers, Siemens is also a world-leading supplier of medical technology and digital health services.